These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses. Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Kinner E; Schuster E; Passik S; France CR Pain; 2013 Sep; 154(9):1856-1864. PubMed ID: 23748117 [TBL] [Abstract][Full Text] [Related]
3. Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness. Burns JW; Bruehl S; France CR; Schuster E; Orlowska D; Chont M; Gupta RK; Buvanendran A J Pain; 2017 Aug; 18(8):923-932. PubMed ID: 28365372 [TBL] [Abstract][Full Text] [Related]
4. The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids. Bruehl S; Burns JW; Morgan A; Koltyn K; Gupta R; Buvanendran A; Edwards D; Chont M; Kingsley PJ; Marnett L; Stone A; Patel S Pain; 2019 Mar; 160(3):676-687. PubMed ID: 30562268 [TBL] [Abstract][Full Text] [Related]
5. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients. Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658 [TBL] [Abstract][Full Text] [Related]
6. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300 [TBL] [Abstract][Full Text] [Related]
7. Self-reported cumulative medical opioid exposure and subjective responses on first use of opioids predict analgesic and subjective responses to placebo-controlled opioid administration. Bruehl S; Stone AL; Palmer C; Edwards DA; Buvanendran A; Gupta R; Chont M; Kennedy M; Burns JW Reg Anesth Pain Med; 2019 Jan; 44(1):92-99. PubMed ID: 30640659 [TBL] [Abstract][Full Text] [Related]
8. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients. Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272 [TBL] [Abstract][Full Text] [Related]
9. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Wasan AD; Davar G; Jamison R Pain; 2005 Oct; 117(3):450-461. PubMed ID: 16154274 [TBL] [Abstract][Full Text] [Related]
10. Do Resting Plasma β-Endorphin Levels Predict Responses to Opioid Analgesics? Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Orlowska D; Schuster E; France CR Clin J Pain; 2017 Jan; 33(1):12-20. PubMed ID: 27183154 [TBL] [Abstract][Full Text] [Related]
11. Opioid Specific Effects on Central Processing of Sensation and Pain: A Randomized, Cross-Over, Placebo-Controlled Study. Lelic D; Olesen AE; Grønlund D; Jure FA; Drewes AM J Pain; 2021 Nov; 22(11):1477-1496. PubMed ID: 34229074 [TBL] [Abstract][Full Text] [Related]
12. Parental history of chronic pain may be associated with impairments in endogenous opioid analgesic systems. Bruehl S; Chung OY Pain; 2006 Oct; 124(3):287-294. PubMed ID: 16725261 [TBL] [Abstract][Full Text] [Related]
13. What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function? Bruehl S; Burns JW; Chung OY; Chont M Eur J Pain; 2012 Mar; 16(3):370-80. PubMed ID: 22337161 [TBL] [Abstract][Full Text] [Related]
14. Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration. Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Schuster E; France CR Reg Anesth Pain Med; 2014; 39(2):120-5. PubMed ID: 24553304 [TBL] [Abstract][Full Text] [Related]
15. Does aerobic exercise training alter responses to opioid analgesics in individuals with chronic low back pain? A randomized controlled trial. Bruehl S; Burns JW; Koltyn K; Gupta R; Buvanendran A; Edwards D; Chont M; Wu YH; Stone A Pain; 2021 Aug; 162(8):2204-2213. PubMed ID: 33394881 [TBL] [Abstract][Full Text] [Related]
16. Greater Conditioned Pain Modulation Is Associated With Enhanced Morphine Analgesia in Healthy Individuals and Patients With Chronic Low Back Pain. Bruehl S; France CR; Stone AL; Gupta R; Buvanendran A; Chont M; Burns JW Clin J Pain; 2021 Jan; 37(1):20-27. PubMed ID: 33086239 [TBL] [Abstract][Full Text] [Related]
17. Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study. Block L; Lundborg C; Bjersing J; Dahm P; Hansson E; Biber B Clin J Pain; 2015 Nov; 31(11):968-75. PubMed ID: 25629634 [TBL] [Abstract][Full Text] [Related]
18. Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: a case report. Hamann S; Sloan PA; Witt W J Opioid Manag; 2008; 4(4):251-4. PubMed ID: 18837205 [TBL] [Abstract][Full Text] [Related]
19. Endogenous opioids and chronic pain intensity: interactions with level of disability. Bruehl S; Chung OY; Ward P; Johnson B Clin J Pain; 2004; 20(5):283-92. PubMed ID: 15322434 [TBL] [Abstract][Full Text] [Related]
20. Anger and pain sensitivity in chronic low back pain patients and pain-free controls: the role of endogenous opioids. Bruehl S; Burns JW; Chung OY; Ward P; Johnson B Pain; 2002 Sep; 99(1-2):223-33. PubMed ID: 12237200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]